Last reviewed · How we verify

NCT04734912

Evaluation of Transnasal Endoscopy During COVID-19 Pandemic

Status unknown NA Last updated 2 February 2021
What this trial tests

NA trial testing gastroscopy in transnasal techique in Endoscopy in 500 participants. Status unknown.

Timeline
13 January 2021
Primary endpoint
15 June 2021
31 December 2021

Quick facts

Lead sponsorJohannes Gutenberg University Mainz
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment500
Start date13 January 2021
Primary completion15 June 2021
Estimated completion31 December 2021
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Johannes Gutenberg University Mainz

Who can join

Adults 18 to 75, any sex, with Endoscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients who received the indication for endoscopic diagnostics using gastroscopy in transnasal technique will be included into the study. The examination is carried out in standard technique and is not influenced by the study. Following the examination, patient data is collected pseudonymously and a questionnaire is submitted to the patient.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Endoscopy

Currently open trials in the same condition.

Other Johannes Gutenberg University Mainz trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04734912.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing